NCT01766167

Clinical Pharmacology Study of MP-424

Clinical Pharmacology Study of MP-424 in Healthy Male Adult Volunteers (Single- and Multiple-Dose Study)

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 26 (actual)
• Sponsor: Tanabe Pharma Corporation · Industry
• Sex: Male
• Age: 20 Years – 55 Years
• Healthy volunteers: Accepted

Summary

To conduct the following evaluations in Korean healthy male adult volunteers receiving a single and multiple doses of MP-424 tablets: * Pharmacokinetics of MP-424 after a single and multiple doses. * Safety and tolerability of single and multiple doses of MP-424.

Conditions

• Chronic Hepatitis C

Interventions

Type	Name	Description
DRUG	MP-424	Low
DRUG	MP-424	Middle
DRUG	MP-424	High
DRUG	MP-424	Multiple

Timeline

• Start date: 2013-02-01
• Primary completion: 2013-04-01
• Completion: 2013-04-01
• First posted: 2013-01-11
• Last updated: 2017-01-26

Locations

1 site across 1 country: South Korea